DAVITA INC. — Director's Dealing 2016

Aug 12, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DAVITA HEALTHCARE PARTNERS INC. (DVA)
CIK: 0000927066
Period of Report: 2016-08-09

Reporting Person: STAFFIERI MICHAEL DAVID (COO, Kidney Care)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-08-09	Common Stock	M	40000	$37.185	Acquired	52279	Direct
2016-08-09	Common Stock	F	19738	$75.36	Disposed	32541	Direct
2016-08-09	Common Stock	S	20262	$73.0872	Disposed	12279	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-08-09	Stock Appreciation Rights	$37.185	M	40000	Disposed	2016-08-09	Common Stock (40000)	Direct

Footnotes

F1: The exercise and sale reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 23, 2016.

F2: Represents the weighted average sale price of $73.0872. The range of prices for the sale of these shares was $72.43 - $73.93, rounded to the nearest hundredth. The reporting person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F3: The Stock Appreciation Rights were granted on 8/9/2011. 50% vested on 8/9/2014, then 8.33% vested every three months thereafter.